An Indian national living in Illinois has pleaded guilty to participating in a $227 million Medicare fraud scheme that used patients’ personal information purchased from a Pakistan-based company to submit false claims for COVID-19 test kits. US authorities said the scheme generated approximately $136 million in payments for tests that beneficiaries had neither ordered nor received.
Who Admitted Involvement?
Syed Murtuza Kablazada, 36, of Des Plaines, Illinois, pleaded guilty to two counts of healthcare fraud in federal court. He faces a maximum sentence of 20 years in prison. His sentencing date has not yet been announced, and the court has not imposed a sentence.
How Did the Scheme Operate?
According to court documents, the operation ran for around six months beginning in January 2023.
Kablazada and his alleged associates acquired three laboratories in the Chicago area, identified as Chicago Care, V Care and Al-Ameer. The laboratories were then used to submit Medicare reimbursement claims for over-the-counter COVID-19 tests that were never requested or delivered to beneficiaries.
Where Did the Patient Information Come From?
Prosecutors said Kablazada paid approximately $11 million to a telemarketing company based in Pakistan.
The company allegedly provided identifying information belonging to hundreds of thousands of Medicare beneficiaries, including details needed to prepare reimbursement claims.
https://the420.in/fcrf-certified-chief-ai-officer-second-cohort-november-2026/
Investigators said those records enabled the laboratories to seek payments without the beneficiaries’ knowledge or consent.
How Much Money Was Involved?
Authorities said the laboratories billed Medicare approximately $227 million through fraudulent claims, of which around $136 million was paid. Prosecutors alleged that participants attempted to conceal their involvement by moving funds overseas and using unlicensed money transmitters.
Some proceeds were also allegedly spent on luxury vehicles. Under his plea agreement, Kablazada agreed to forfeit more than $46 million already seized from 10 bank accounts associated with the investigation.
Who Investigated the Case?
The investigation was led by the FBI’s Chicago Field Office and the US Department of Health and Human Services Office of Inspector General.
The Justice Department’s healthcare fraud investigators are prosecuting the case with assistance from federal prosecutors in northern Illinois. The case remains before the federal court for sentencing.
The420 Insight: Why Does This Matter?
The case demonstrates how purchased medical identity data can be exploited to generate false insurance claims on a large scale. It also highlights the financial risks created when sensitive patient information moves across borders and is used without the individuals’ knowledge.
